Market Overview:
An aseptic isolator protects the product from environmental pollutants. Positive pressure is maintained in the isolator to guarantee that particles from the setup room do not enter and contaminate the product in the event of even a little leak. Aseptic process isolation is not a novel technique. Flexible film isolation has been used in aseptic processing since the 1970s, albeit early systems tended to be a combination of stainless-steel chambers and airflow modules with a flexible film user interface.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | ILC Dover (United States), Esco Pharma (Singapore), Thermo Fisher Scientific (United States), OPTIMA packaging group GmbH (Germany), ESI Group (France), Syntegon Technology (Germany), Sartorius AG (Germany), Sigma-Aldrich (United States), Getinge (Sweden) and R-Biopharm AG (Germany) |
CAGR | % |
Influencing Trend:
Emergence of Non-Viable Particle Monitoring and Advent of Dehydrogenation Tunnels and Automatic Lyophilized Loading
Market Growth Drivers:
Increase in Demand to Reduce the Microbial Contamination Risk and Rise in Demand for Small Molecule Drugs and Vaccines
Challenges:
Risk of Human Intervention and Aseptic Isolation Could Cause Damage, Degradation, or Inactivation of the Final Product
The key Players profiled in the report are ILC Dover (United States), Esco Pharma (Singapore), Thermo Fisher Scientific (United States), OPTIMA packaging group GmbH (Germany), ESI Group (France), Syntegon Technology (Germany), Sartorius AG (Germany), Sigma-Aldrich (United States), Getinge (Sweden) and R-Biopharm AG (Germany). Additionally, other players that are of this comprehensive study are Ortner (Austria), Jointechlabs (United States) and Aseptic Technologies (Belgium).
Market Development Activities
In September 2020 ILC Dover released a statement announcing the acquisition of Solo Containment. ILC Dover's highlighted brands, which include DoverPac®, EZ BioPac®, and ArmorFlex®, will now be augmented by a variety of HPAPI containment and aseptic isolator operating platforms, as well as industry-leading Solo brands like as soloASEPTIC, soloLAB, soloFLEX, soloVERSO, and soloADC. The purchase also offers ILC Dover with a European centre of expertise, allowing for even better support and response to clients in that region.
In April 13, 2021 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, today introduced the soloPURE™ flexible aseptic isolator, a cost-effective, closed-barrier system for sterile manufacturing.
Key Target Audience
Venture and Capitalist, Raw materials Suppliers, New entrants/investors, Hospitals and End-use industries